Mahamaya Lifescience
Ticker > Company >

Mahamaya Lifescience share price

Mahamaya Lifesciences Ltd.

 34   0   0

The company is currently not listed and is under IPO, so all the data might not be available.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Ratios

Sales Growth

1 Year63.49%
3 Year43.22%
5 YearNA

Profit Growth

1 Year134.38%
3 Year65.99%
5 YearNA

ROE%

1 Year34.17%
3 Year26.48%

ROCE %

1 Year26%
3 Year22.8%

Debt/Equity

1.1638

Price to Cash Flow

0

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

 Strengths

  • The company has shown a good revenue growth of 43.2209900110013% for the Past 3 years.
  • Company has been maintaining healthy ROE of 26.4765666666667% over the past 3 years.
  • Company has been maintaining healthy ROCE of 22.8035333333333% over the past 3 years.
  • The company has an efficient Cash Conversion Cycle of 0 days.

 Limitations

  • Company has low Interest coverage ratio of 0.
  • Company has negative cash flow from operations of -3.3489.
  • The company has a low EBITDA margin of 0% over the past 5 years.

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 89.91 137.08 161.57 264.15
Total Expenditure 83.36 127.89 147.93 240.99
Operating Profit 6.55 9.18 13.65 23.15
Other Income 0.18 0.31 1.25 3.02
Interest 1.84 2.97 5.97 7.14
Depreciation 0.94 1.32 1.41 1.77
Exceptional Items 0 0 0 0
Profit Before Tax 3.95 5.21 7.52 17.26
Tax 1.14 1.48 2.05 4.44
Net Profit 2.8 3.73 5.47 12.82
Adjusted EPS (Rs.) 2.04 2.71 3.98 7.22

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 1.25 1.25 1.25 17.77
Total Reserves 14.73 18.46 23.93 32.1
Borrowings 9.68 10.3 8.55 6.16
Other N/C liabilities 0.21 0.47 0.77 1.15
Current liabilities 30.08 47.79 77.99 131.54
Total Liabilities 55.95 78.27 112.49 188.71
Assets
Net Block 17.9 20.05 20.53 26.42
Capital WIP 0 0 0 0
Intangible WIP 2.34 2.17 2.96 4.12
Investments 0.05 0.05 0.05 0.05
Loans & Advances 0.33 0.33 0.33 0.45
Other N/C Assets 1.72 1.29 0.97 0.64
Current Assets 33.61 54.38 87.66 157.04
Total Assets 55.95 78.27 112.49 188.71
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2024 Mar 2025
Profit from operations 7.52 17.26
Adjustment 7.03 8.34
Changes in Assets & Liabilities -36.82 -27.1
Tax Paid -1.19 -1.86
Operating Cash Flow -23.46 -3.35
Investing Cash Flow -1.38 -4.43
Financing Cash Flow 24.53 8.47
Net Cash Flow -0.31 0.69

Corporate Actions

Last Updated on:
Brief about Mahamaya Lifescience
X